TY  - CONF 
AU  - Ferreiro Iglesias, Rocio
AU  - Jardi Cuadrado, Andrea
AU  - Quiroga Castiñeira, Adriano
AU  - Bastón Rey, Iria
AU  - Gonzalez, J.
AU  - Giraldez Montero, José María
AU  - ZARRA FERRO,  IRENE
AU  - Lamas Díaz, María Jesús
AU  - Domínguez Muñoz,  Juan Enrique
AU  - Barreiro de Acosta, Manuel
PY  - 2019
SN  - 1873-9946
UR  - http://hdl.handle.net/20.500.11940/15633
AB  - Background
Dose escalation is often recommended for loss of response in patients with inflammatory bowel disease (IBD) under maintenance treatment with anti-TNF, but in normal conditions this strategy considerably increases the cost. A new...
LA  - eng
TI  - Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified IBD patients under treatment with adalimumab 40 mg every week
DO  - 10.1093/ecco-jcc/jjy222.677
KW  - CHUS
VL  - 13
ER  -